1999
DOI: 10.1002/(sici)1097-4598(199907)22:7<889::aid-mus12>3.0.co;2-b
|View full text |Cite
|
Sign up to set email alerts
|

Transforming growth factor-?2 is elevated in skeletal muscle disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
30
0
1

Year Published

2000
2000
2013
2013

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 57 publications
(33 citation statements)
references
References 33 publications
2
30
0
1
Order By: Relevance
“…In muscles of patients with myotubular myopathy, low levels of CTGF were observed at the center of myofibers. Murakami et al reported the immunolocalization of TGF-beta2 at the center of myofibers in patients with myotubular myopathy [46]. This suggests that growth factors have a role other than that in the regeneration of muscle fibers, but this role has yet to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…In muscles of patients with myotubular myopathy, low levels of CTGF were observed at the center of myofibers. Murakami et al reported the immunolocalization of TGF-beta2 at the center of myofibers in patients with myotubular myopathy [46]. This suggests that growth factors have a role other than that in the regeneration of muscle fibers, but this role has yet to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Another cytokine that may be of importance in muscle regeneration in the absence of TNF-␣ is transforming growth factor-beta (TGF-␤) (Derynck and Choy 1998). In particular, TGF-␤ is a modulator of myoblast differentiation and fusion and in remodeling of the extracellular matrix (Murakami et al 1999). TGF-␤ also attenuates the inflammatory response and inhibits the activity andրor production of a number of cytokines, including TNF-␣, LT-␣, and IL-1 (Derynck and Choy 1998).…”
Section: Cytokine Interactionsmentioning
confidence: 99%
“…TGF-␤ also attenuates the inflammatory response and inhibits the activity andրor production of a number of cytokines, including TNF-␣, LT-␣, and IL-1 (Derynck and Choy 1998). Like TNF-␣, TGF-␤ is also elevated in skeletal muscle disorders (Murakami et al 1999). However, because the muscles of TGF-␤(-ր-) mice appear normal (McLennan et al 2000), this indicates that other genes are capable of substituting for the missing TGF-␤ in vivo.…”
Section: Cytokine Interactionsmentioning
confidence: 99%
“…In myopathies such as Duchenne muscular dystrophy (DMD), the regeneration process is compromised, and muscle tissue is replaced by dysfunctional scar (fibrotic) tissue. Levels of TGF-b1 and TGF-b2 are elevated in muscular dystrophies and have been shown to cause fibrosis in dystrophic muscles (Bernasconi et al, 1995;Bernasconi et al, 1999;Murakami et al, 1999;Zhu et al, 2007). Interestingly, inhibition of TGF-b signaling not only prevents fibrosis, but also improves regeneration in mdx mutants that are widely studied as a mouse model for DMD (Lefaucheur and Sébille, 1995;Cohn et al, 2007), indicating that regulation of fibrosis presents a key step in the pathology of DMD.…”
Section: Introductionmentioning
confidence: 99%